You are here: Industry Insights > COVID-19

News List

COVID-19 Vaccine Trials Resume in UK americanpharmaceuticalreview
September 16, 2020
Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so.
BioNTech to Receive German Federal Ministry Funding for COVID-19 Vax contractpharma
September 16, 2020
?BioNTech SE will receive a grant of up to $445.4 million) from an initiative by the German Federal Ministry of Education and Research (BMBF) to support the accelerated development of SARS-CoV-2 vaccines.
Valneva, Dynavax Enter COVID-19 Vax Supply Pact contractpharma
September 16, 2020
Dynavax will supply CpG 1018 to produce up to 100 million doses of VLA2001 vaccine in 2021.
Baricitinib in combination with remdesivir reduces recovery time in hospitalised COVID-19 patients: Study expresspharma
September 16, 2020
Data from the Adaptive COVID-19 Treatment Trial (ACTT-2) revealed an approximately one-day reduction in median recovery time for the overall patient population.
Which immune response could cause a vaccine against COVID-19? worldpharmanews
September 15, 2020
Immune reactions caused by vaccination can help protect the organism, or sometimes may aggravate the condition. It is especially important now when multiple vaccines against COVID-19 are being developed.
Phase I trial finds potential COVID-19 antibody treatment safe in healthy volunteers europeanpharmaceuticalreview
September 15, 2020
A first-in-human Phase I clinical trial of potential COVID-19 antibody CT-P59 has shown the treatment is well tolerated in healthy subjects.
Leukemia & Lymphoma Society Launches Trial for Blood Cancer Patients with COVID-19 americanpharmaceuticalreview
September 15, 2020
The Leukemia & Lymphoma Society (LLS) is launching the first clinical trial for blood cancer patients at risk of death if infected with the COVID-19 virus.
Ampio Reports Positive Results for Ampion Treatment in COVID-19 Patients americanpharmaceuticalreview
September 15, 2020
Ampio Pharmaceuticals announced positive results in early trial for intravenous (IV) Ampion treatment for COVID-19 patients.
Discord between IMA and MSN Labs over promotion of COVID-19 drug, Favilow expresspharma
September 15, 2020
The doctors’ body claims misuse of its identity in the drug’s promotion while the pharma firm asserts that it has email expressing support from the former.
Kiadis to collaborate with Abigail Wexner Research Institute for clinical trials of COVID-19 therapy expresspharma
September 15, 2020
The US FDA approved AWRI’s investigational new drug application (IND) for a study in an adult population with off-the-shelf natural killer (NK) cells.